Dropped‐head syndrome in a patient under treatment with the MEK inhibitor trametinib for NRAS‐mutated metastatic melanoma. (1st March 2018) - Kleemann, J.; Hrgovic, I.; Hempel, K.; Kaufmann, R.; Meissner, M.